• Presenting authors of abstracts must be registered participants of the meeting.
  • Abstracts must be submitted and presented in clear English or French with accurate grammar and spelling.
  • Abstracts must be received by the deadline. Abstracts received after the deadline will not be considered.
  • Abstracts stating "data will be discussed in the presentation" will not be accepted.

When submitting the abstract, the Abstract Submitter have to confirm the following:

  • All named authors have previewed this abstract and that all information is correct.
  • All named authors are sole owners or have the rights of all the information and content.
  • I confirm that the contact details are those of the corresponding author, who will be notified about the status of the abstract. The corresponding author is responsible for informing the co- authors about the status of the abstract.


MSF abstracts must have had ethics oversight and been approved for submission to MSF Paediatric Days by the Medical Director from the Operational Centre responsible for the research. Please see the MSF Ethics Review Board (ERB) for guidance. For research from other organisations, abstracts should have the relevant Ethics Committee oversight.

For MSF staff, we will verify if that the study you are submitted have been approved by the Medical Director of your section by sharing the list of submitted abstracts with the Medical Director of each Operational Center.




    • Presenting author's and Co-authors' details
      • Full first and family name(s).
      • Affiliation details: Mission, Project, Operative Centre, country, email address (corresponding author)
    • Abstract title – limited to 25 words in UPPER CASE
    • Abstract text – limited to 300 words. We recommend using word-processing software (for example, Word) for editing your abstract and counting the number of words.


    • Abstracts should be structured and clearly state:
      • Background and aims
      • Methods
      • Results
      • Conclusions


    • For Case studies please use the following structure:
      • Introduction
      • Case Description
      • Discussion

    More information about this format here.

    • Use only standard abbreviations. Place special or unusual abbreviations in parentheses after the full word appear the first time.
    • Use generic names of drugs. Express numbers as numerals.
    • Tables – A maximum of 2 tables of up to 10 rows x 10 columns can be included per abstract.
    • Graphs and Images – A maximum of 2 images can be included per abstract.



    Disclosure of financial relationships that the author(s) may have with the manufacturer/ supplier of any commercial products or services related to the work, should be indicated in the appropriate box on the abstract form.